HETERODIMERIC ANTIBODIES THAT BIND MSLN AND CD3
The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Mesothelin (MSLN).
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
22.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind Mesothelin (MSLN). |
---|---|
Bibliography: | Application Number: EP20210730426 |